Skip to main content
CTIS.
EU
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
EN — English
BG — Български
CS — Čeština
DA — Dansk
DE — Deutsch
EL — Ελληνικά
ES — Español
ET — Eesti
FI — Suomi
FR — Français
GA — Gaeilge
HR — Hrvatski
HU — Magyar
IT — Italiano
LT — Lietuvių
LV — Latviešu
MT — Malti
NL — Nederlands
PL — Polski
PT — Português
RO — Română
SK — Slovenčina
SL — Slovenščina
SV — Svenska
NO — Norsk
CTIS.
EU
✕
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
Notice
This is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
CTIS.eu
›
Conditions
› Non-Hodgkin's lymphoma unspecified histology aggressive recurrent
Non-Hodgkin's lymphoma unspecified histology aggressive recurrent
2 total trials
1 recruiting
MedDRA PT
Filter these 2 trials by phase, country, sponsor and more.
Open in Search →
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressi …
Recruiting
2022-502783-21-00
5
2024-02-20
"B-Cell Non-Hodgkin's Lymphoma"
A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas
Halted
2022-502137-26-00
1
2024-05-03
"B-cell Non-Hodgkins Lymphoma (B-NHL)"
Showing 1–2 of 2 trials